8-K 1 c81010e8vk.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) November 12, 2003 ALLIED HEALTHCARE PRODUCTS, INC. -------------------------------- (Exact name of registrant as specified in its charter) DELAWARE 1-19266 25-1370721 ------------------------------- ---------------- ------------------- (State or other jurisdiction of (Commission File (I.R.S. Employe incorporation or organization) number) Identification No.) 1720 SUBLETTE AVENUE, ST. LOUIS, MISSOURI 63110 ----------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (314) 771-2400 ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS. (c) Exhibits 99.1 Press release issued on November 12, 2003 ITEM 12. RESULTS OF OPERATION AND FINANCIAL CONDITION. The press release regarding Third Quarter 2003 financial results attached as Exhibit 99.1 hereto was issued by the Company on November 12, 2003. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: November 13, 2003 ALLIED HEALTHCARE PRODUCTS, INC. By: /s/ Daniel C. Dunn ---------------------------- Daniel C. Dunn Vice President and Chief Financial Officer EXHIBIT INDEX
EXHIBIT NUMBER DESCRIPTION OF EXHIBIT PAGE -------------- ----------------------------------------- ---- 99.1 Press release issued on November 12, 2003 3